Skip to content
Tuesday 11 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,862.50
-0.35%
DAX
26,323.88
+0.02%
CAC 40
8,726.03
0.00%
STOXX 50
6,535.62
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Thursday 02 October 2014 10:13 am  |  Updated:  Friday 07 June 2019 11:54 am

Ebola outbreak: Man quarantined in Hawaii hospital

By: Sarah Spickernell

Add as a preferred source on Google

A man suspected of being infected with the Ebola virus has been quarantined at a hospital in Hawaii. 
 
He is currently being treated in isolation at the island's Queen’s Medical Center in Honolulu, where health officials said he was sent after showing symptoms of the disease. 
 
However, spokespeople said the team was being especially cautious in its diagnosis, noting the symptoms could be the result of a different disease. 
 
“We are early in the investigation of a patient — very, very early — who we’re investigating that might have Ebola,”  Dr Melissa Viray of the Hawaii department of health told NY Daily News.
 
“It’s very possible that they do and they have Ebola. I think it’s also more likely that they have another condition that presents with similar symptoms.”
 
The man has not yet been tested for the virus, and for patient confidentiality reasons it has not been made clear whether he had recently travelled to West Africa.
 
It was only a day and a half ago that a man in Texas was identified as having contracted the virus. He had recently returned from a trip to Liberia – one of the countries worst affected by the epidemic in West Africa. He was the first person diagnosed as having the disease in the US. 
 
So far, the epidemic which broke out in February has killed over 3,000 people according to the World Health organisation. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Boutique London advisory firm lands £8m funding amid M&A frenzy

  • Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

  • Point2 Completes $136M Series B Funding with Arm, LB Investment, and Maverick Silicon

  • Top economists shun Burnham over wealth taxes

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

More from Morning Wire

  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • Alkermes plc Reports Second Quarter 2026 Financial Results

    Business Wire
  • New Victoria Hospital Goes Live with MEDITECH Expanse to Deliver New Era of Care

    Business Wire
  • Prothena to Report Second Quarter 2026 Financial Results on August 6

    Business Wire
  • Mead Johnson Welcomes Defense Verdict in Collins Case

    Business Wire
  • VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook